{"title":"Research progress on the bioactivity of platycodin D from Platycodon grandifloras.","authors":"Ying Song, Xin Lv, Chuanbo Ding, Xinglong Liu, Yuanyuan Han, Shengyue Chen, Min Li, Ting Zhao","doi":"10.1007/s00210-025-03875-9","DOIUrl":null,"url":null,"abstract":"<p><p>Platycodon grandiflorus, in the family Platycodonaceae, has been traditionally utilized in China to treat sore throats, hoarseness, and coughs with phlegm. As a medicinal and food plant, P. grandiflorus has a long history of use. Recent research on natural medicine has highlighted the biological activity and potential medicinal benefit of P. grandiflorus, which has prompted in-depth studies. One of the main active compounds extracted from the root of this plant is platycodin D (PD). This compound has various beneficial properties, including anti-inflammatory, antitumor, antioxidant, metabolic regulatory, antiviral, hepatoprotective, and spermatogenic effects. Additionally, PD can serve as a vaccine adjuvant to increase the efficacy of vaccines. This article explores the potential mechanism of action in treating hepatocellular carcinoma, breast cancer, lung cancer, and diabetes. The pharmacokinetics and bioavailability of PD are also discussed. With advancements in basic research and clinical applications, PD is anticipated to become a significant therapeutic agent for treating inflammatory diseases, metabolic disorders, and cancer.</p>","PeriodicalId":18876,"journal":{"name":"Naunyn-Schmiedeberg's archives of pharmacology","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Naunyn-Schmiedeberg's archives of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00210-025-03875-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Platycodon grandiflorus, in the family Platycodonaceae, has been traditionally utilized in China to treat sore throats, hoarseness, and coughs with phlegm. As a medicinal and food plant, P. grandiflorus has a long history of use. Recent research on natural medicine has highlighted the biological activity and potential medicinal benefit of P. grandiflorus, which has prompted in-depth studies. One of the main active compounds extracted from the root of this plant is platycodin D (PD). This compound has various beneficial properties, including anti-inflammatory, antitumor, antioxidant, metabolic regulatory, antiviral, hepatoprotective, and spermatogenic effects. Additionally, PD can serve as a vaccine adjuvant to increase the efficacy of vaccines. This article explores the potential mechanism of action in treating hepatocellular carcinoma, breast cancer, lung cancer, and diabetes. The pharmacokinetics and bioavailability of PD are also discussed. With advancements in basic research and clinical applications, PD is anticipated to become a significant therapeutic agent for treating inflammatory diseases, metabolic disorders, and cancer.
期刊介绍:
Naunyn-Schmiedeberg''s Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg''s Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.